Skip to content
← Full study record

NCT03220022 · MORE INFO

Limitations, agreements, and source contact

Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas · Source last updated 2026-08-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
deukwoo.kwon@mountsinai.org
organization
Statistical and Data Analysis Center, AIDS Malignancy Consortium
phone
(501) 525-6724
title
Deukwoo Kwon
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
deukwoo.kwon@mountsinai.org
organization
Statistical and Data Analysis Center, AIDS Malignancy Consortium
phone
(501) 525-6724
title
Deukwoo Kwon

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice